SCHEMBL29566967

SCHEMBL29566967

CCCc1c(Oc2ccc(C3CCN(C)CC3)cc2)nc(NS(=O)(=O)c2cnn(C)c2)nc1-c1ccccc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 5/20 0.35
▸ HTR7 P34969 5/20 0.35
▸ SLC8A1 P32418 1/20 0.33
▸ BRD4 O60885 2/20 0.33
▸ JAK2 O60674 3/20 0.32
▸ JAK3 P52333 3/20 0.32
▸ PTK2 Q05397 3/20 0.32
▸ GRIN2D O15399 1/20 0.32
▸ GRIN2A Q12879 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ GRIN2C Q14957 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ HTR6 P50406 1/20 0.32
▸ IGF1R P08069 1/20 0.31
▸ MAP4K1 Q92918 2/20 0.31
▸ MAP4K3 Q8IVH8 1/20 0.31
▸ PCK1 P35558 1/20 0.31
▸ SCN9A Q15858 1/20 0.31
▸ MMP3 P08254 1/20 0.31
▸ CACNA2D1 P54289 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310801 1.00 HTR1A (0.35) HTR1AHTR7SLC8A1BRD4JAK2
SCHEMBL26811478 0.94 HTR1A (0.36) HTR1AHTR7SLC8A1BRD4JAK2
SCHEMBL29567061 0.90 HTR1A (0.37) HTR1AHTR7SLC8A1BRD4JAK2
SCHEMBL24309783 0.90 HTR1A (0.37) HTR1AHTR7SLC8A1BRD4JAK2
SCHEMBL29567168 0.90 BRD4 (0.35) HTR1AHTR7SLC8A1BRD4JAK2
SCHEMBL24310081 0.90 BRD4 (0.35) HTR1AHTR7SLC8A1BRD4JAK2
SCHEMBL24309924 0.89 HTR1A (0.36) HTR1AHTR7SLC8A1BRD4JAK2
SCHEMBL29566432 0.89 HTR1A (0.36) HTR1AHTR7SLC8A1BRD4JAK2
SCHEMBL24310732 0.89 HTR1A (0.36) HTR1AHTR7SLC8A1BRD4JAK2
SCHEMBL24309436 0.89 HTR1A (0.36) HTR1AHTR7SLC8A1BRD4JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback